PB 12 of 2017

National Health (Weighted average disclosed price – April 2017 reduction day) Amendment Determination 2017 (No.1)

National Health Act 1953

I, LOUISE CLARKE, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.

Dated:  17 January 2017

 

 

 

 

 

 

 

 

 

LOUISE CLARKE

 

Acting First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

 

1 Name of Determination

 (1) This Determination is the National Health (Weighted average disclosed price April 2017 reduction day) Amendment Determination 2017 (No.1).

 (2) This Determination may also be cited as PB 12 of 2017.

2 Commencement

  This Determination commences on the day after it is registered.

 

3                             Amendments to PB 109 of 2016

Schedule 1 amends the National Health (Weighted average disclosed priceApril 2017 reduction day) Determination 2016 (PB 109 of 2016).

Schedule 1  Amendments

 

[1]  Schedule 1

omit:

470

Iron polymaltose complex

Injection 100 mg (iron) in 2 mL

Injection

Ferrosig

7.53

471

Iron polymaltose complex

Injection 100 mg (iron) in 2 mL

Injection

Ferrum H

7.53

 

[2]  Schedule 1

omit:

1034

Sorbitol with sodium citrate and sodium lauryl sulfoacetate

Enemas 3.125 g-450 mg-45 mg in 5 mL, 12

Rectal

Micolette

7.28

 

[3]  Schedule 1

omit:

1135

Ursodeoxycholic acid

Capsule 250 mg

Oral

Ursodox GH

116.74

1136

Ursodeoxycholic acid

Capsule 250 mg

Oral

Ursofalk

116.74

1137

Ursodeoxycholic acid

Capsule 250 mg

Oral

Ursosan

116.74

 

[4]  Schedule 1

omit:

1153

Zoledronic acid

Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL

Injection

APO-Zoledronic Acid

244.25

1154

Zoledronic acid

Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL

Injection

DBL Zoledronic Acid

244.25

1155

Zoledronic acid

Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL

Injection

Zometa

244.25

1156

Zoledronic acid

Solution for I.V. infusion 4 mg (as monohydrate) in 100 mL

Injection

DBL Zoledronic Acid

244.25

1157

Zoledronic acid

Solution for I.V. infusion 4 mg (as monohydrate) in 100 mL

Injection

Zometa

244.25

1158

Zoledronic acid

Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL

Injection

Aclasta

327.01

1159

Zoledronic acid

Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL

Injection

Osteovan

327.01

1160

Zoledronic acid

Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL

Injection

Ostira

327.01

1161

Zoledronic acid

Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL

Injection

Zoledasta

327.01

substitute:

1153

Zoledronic acid

Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL

Injection

APO-Zoledronic Acid

245.33

1154

Zoledronic acid

Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL

Injection

DBL Zoledronic Acid

245.33

1155

Zoledronic acid

Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL

Injection

Zometa

245.33

1156

Zoledronic acid

Solution for I.V. infusion 4 mg (as monohydrate) in 100 mL

Injection

DBL Zoledronic Acid

245.33

1157

Zoledronic acid

Solution for I.V. infusion 4 mg (as monohydrate) in 100 mL

Injection

Zometa

245.33

1158

Zoledronic acid

Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL

Injection

Aclasta

328.46

1159

Zoledronic acid

Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL

Injection

Osteovan

328.46

1160

Zoledronic acid

Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL

Injection

Ostira

328.46

1161

Zoledronic acid

Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL

Injection

Zoledasta

328.46

 

[4]  Schedule 2

after:

1032

Irbesartan with hydrochlorothiazide

Tablet 300 mg-25 mg

Oral

Terry White Chemists Irbesartan HCTZ

4.54

insert:

1032A

Iron polymaltose complex

Injection 100 mg (iron) in 2 mL

Injection

Ferrosig

11.63

1032B

Iron polymaltose complex

Injection 100 mg (iron) in 2 mL

Injection

Ferrum H

11.63

 

[5]  Schedule 2

after:

2116

Somatropin

Solution for injection 6 mg (18 i.u.) in 1.03 mL cartridge (with preservative)

Injection

Saizen

249.48

insert:

2116A

Sorbitol with sodium citrate and sodium lauryl sulfoacetate

Enemas 3.125 g-450 mg-45 mg in 5 mL, 12

Rectal

Micolette

8.05

 

[6]  Schedule 2

after:

2302

Tropisetron

I.V. injection 5 mg (as hydrochloride) in 5 mL

Injection

Tropisetron-AFT

4.74

insert:

2302A

Ursodeoxycholic acid

Capsule 250 mg

Oral

Ursodox GH

132.03

2302B

Ursodeoxycholic acid

Capsule 250 mg

Oral

Ursofalk

132.03

2302C

Ursodeoxycholic acid

Capsule 250 mg

Oral

Ursosan

132.03